Abstract
The aim of the present study was to investigate the relationship between hypothyroidism and thrombocytopenia in hepatitis B-related compensatory liver cirrhosis and to determine whether treatment with levothyroxine and prednisone is superior in a multicenter, open-label, observational study in China. In total, 125 consecutive hepatitis B-related compensated liver cirrhosis patients with severe thrombocytopenia accompanied by hypothyroidism were included. The patients were divided into four groups according to treatment strategy: a control group (n=29), a prednisone group (n=25), a levothyroxine group (n=32) and a prednisone plus levothyroxine group (n=39). Severe thrombocytopenia was more prevalent in hepatitis B-associated compensatory liver cirrhosis patients with hypothyroidism than in euthyroid patients (29.6% vs. 14.7%, P<0.05). Combination treatment with prednisone and levothyroxine decreased the risk of bleeding and improved platelet recovery compared to control treatment and treatment with either prednisone or levothyroxine alone. The platelet count before therapy, serum thyroid stimulating hormone and combination treatment with prednisone and levothyroxine were associated with bleeding events. Therefore, the present study suggests that hypothyroidism is associated with severe thrombocytopenia in hepatitis B-associated compensatory liver cirrhosis. Treatment with prednisone plus levothyroxine may present a novel approach in these patients.
Similar content being viewed by others
References
Antonelli, A., Ferri, C., Pampana, A., Fallahi, P., Nesti, C., Pasquini, M., Marchi, S., and Ferrannini, E. (2004). Thyroid disorders in chronic hepatitis C. Am J Med 117, 10–13.
Atalay, R., Ersoy, R., Demirezer, A.B., Akın, F.E., Polat, S.B., Cakir, B., and Ersoy, O. (2015). Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver. Endocrine 48, 942–948.
Baskin, H.J., Cobin, R.H., Duick, D.S., Gharib, H., Guttler, R.B., Kaplan, M.M., Segal, R.L., Garber, J.R., Hamilton Jr., C.R., Handelsman, Y., Hellman, R., Kukora, J.S., Levy, P., Palumbo, P.J., Petak, S.M., Rettinger, H.I., Rodbard, H.W., Service, F.J., Shankar, T.P., Stoffer, S.S., Tourtelot, J.B. (2002). American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8, 457–469.
Biró, E., Szekanecz, Z., Czirják, L., Dankó, K., Kiss, E., Szabó, N.A., Szucs, G., Zeher, M., Bodolay, E., Szegedi, G., Bakó, G. (2006). Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25, 240–245.
Blackard, J.T., Kong, L., Huber, A.K., and Tomer, Y. (2013). Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid 23, 863–870.
Bowles, K.M., Turner, G.E., and Wimperis, J.Z. (2004). Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism. J Clin Pathol 57, 995–996.
Brabant, A., Brabant, G., Schuermeyer, T., Ranft, U., Schmidt, F.W., Hesch, R.D., and von zur Muhlen, A. (1989). The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol (Copenh) 121, 95–100.
Cable, E.E., Finn, P.D., Stebbins, J.W., Hou, J., Ito, B.R., van Poelje, P.D., Linemeyer, D.L., and Erion, M.D. (2009). Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 49, 407–417.
Carulli, L., Ballestri, S., Lonardo, A., Lami, F., Violi, E., Losi, L., Bonilauri, L., Verrone, A.M., Odoardi, M.R., Scaglioni, F., Bertolotti, M., and Loria, P. (2013). Is nonalcoholic steatohepatitis associated with a highthough- normal thyroid stimulating hormone level and lower cholesterol levels? Intern Emerg Med 8, 297–305.
Cheung, E., and Liebman, H.A. (2009). Thyroid disease in patients with immune thrombocytopenia. Hematol Oncol Clin North Am 23, 1251–1260.
Committee, W.G.A.b.t.G.R. (2015). Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. (Geneva: World Health Organization).
Cooper, D.S., and Biondi, B. (2012). Subclinical thyroid disease. Lancet 379, 1142–1154.
Ding, W.J., Wang, M.M., Wang, G.S., Shen, F., Qin, J.J., and Fan, J.G. (2015). Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects. J Gastroenterol Hepatol 30, 1753–1758.
Garber, J.R., Cobin, R.H., Gharib, H., Hennessey, J.V., Klein, I., Mechanick, J.I., Pessah-Pollack, R., Singer, P.A., Woeber, K.A., Woeber, K.A. (2012). Clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association. Thyroid 22, 1200–1235.
Haugen, B.R. (2009). Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23, 793–800.
Hou, J.L. (2015). The guideline of prevention and treatment for chronic hepatitis B: a 2015 update (in Chinese). Chin J Hepatol 23, 888–905.
Ioachimescu, A.G., Makdissi, A., Lichtin, A., and Zimmerman, R.S. (2007). Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study. Thyroid 17, 1137–1142.
Kang, M.Y., Hahm, J.R., Jung, T.S., Lee, G.W., Kim, D.R., and Park, M.H. (2006). A 20-year-old woman with Hashimoto’s thyroiditis and Evans’ syndrome. Yonsei Med J 47, 432–436.
Kim, S.U., Lee, J.H., Kim, D.Y., Ahn, S.H., Jung, K.S., Choi, E.H., Park, Y. N., Han, K.H., Chon, C.Y., Park, J.Y. (2012). Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS ONE 7, e36676.
Mansour-Ghanaei, F., Mehrdad, M., Mortazavi, S., Joukar, F., Khak, M., and Atrkar-Roushan, Z. (2012). Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Ann Hepatol 11, 667–671.
Napolitano, M., Malato, A., Raffaele, F., Palazzolo, M., Lo Iacono, G., Pinna, R., Geraci, G., Modica, G., Saccullo, G., Siragusa, S., and Cajozzo, M. (2013). Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia. Blood Transfus 11, 506–509.
Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., Crowther, M. A., and Crowther, M.A. (2011). The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117, 4190–4207.
Page, L.K., Psaila, B., Provan, D., Michael Hamilton, J., Jenkins, J.M., Elish, A.S., Lesser, M.L., and Bussel, J.B. (2007). The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 138, 245–248.
Perra, A., Simbula, G., Simbula, M., Pibiri, M., Kowalik, M.A., Sulas, P., Cocco, M.T., Ledda-Columbano, G.M., and Columbano, A. (2008). Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J 22, 2981–2989.
Pradella, P., Bonetto, S., Turchetto, S., Uxa, L., Comar, C., Zorat, F., De Angelis, V., and Pozzato, G. (2011). Platelet production and destruction in liver cirrhosis. J Hepatol 54, 894–900.
Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kühne, T., Ruggeri, M., George, J.N. (2009). Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113, 2386–2393.
Rugge, B., Balshem, H., Sehgal, R., Relevo, R., Gorman, P., and Helfand, M. (2011). AHRQ Comparative Effectiveness Reviews. In Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (Rockville (MD), Agency for Healthcare Research and Quality (US)).
Sarin, S.K., Kumar, M., Lau, G.K., Abbas, Z., Chan, H.L.Y., Chen, C.J., Chen, D.S., Chen, H.L., Chen, P.J., Chien, R.N., Dokmeci, A.K., Gane, E., Hou, J.L., Jafri, W., Jia, J., Kim, J.H., Lai, C.L., Lee, H.C., Lim, S. G., Liu, C.J., Locarnini, S., Al Mahtab, M., Mohamed, R., Omata, M., Park, J., Piratvisuth, T., Sharma, B.C., Sollano, J., Wang, F.S., Wei, L., Yuen, M.F., Zheng, S.S., Kao, J.H. (2016). Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 10, 1–98.
Sarkar, S., Mondal, R., Nandi, M., and Ghosh, J. (2013). Immune thrombocytopenic purpura in a child with thyroid hormone resistance—a rare presentation. J Pediatr Endocrinol Metab 26, 125–127.
Shen, Y., Wang, X.L., Xie, J.P., Shao, J.G., Lu, Y.H., Zhang, S., and Qin, G. (2016). Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis. J Gastrointestin Liver Dis 25, 227–234.
Tahir, H., Sheraz, F., Sagi, J., and Daruwalla, V. (2016). Immune thrombocytopenia (ITP) secondary to subclinical hashimoto’s thyroiditis: role of levothyroxine in improving the clinical outcome of ITP. J Investig Med High Impact Case Rep 4, 2324709616647085.
Teixeira, P.F.S., Reuters, V.S., Ferreira, M.M., Almeida, C.P., Reis, F.A.A., Melo, B.A., Buescu, A., Costa, A.J.L., and Vaisman, M. (2008). Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res 40, 50–55.
Wong, G.L.H., Chan, H.L.Y., Mak, C.W.H., Lee, S.K.Y., Ip, Z.M.Y., Lam, A.T.H., Iu, H.W.H., Leung, J.M.S., Lai, J.W.Y., Lo, A.O.S., Chan, H.Y., Wong, V.W.S. (2013). Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis. Hepatology 58, 1537–1547.
Wu, Y., You, S., Zang, H., Liu, H., Mao, Y., Mao, P., Zhu, B., Xu, J., Xie, G., Guo, J., Li, D., Xin, S., and Wan, Z. (2015). Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acuteon- chronic liver failure. Ann Hepatol 14, 218–224.
Yang, R., Shan, Z., Li, Y., Fan, C., Li, C., and Teng, W. (2011). Prevalence of thyroid autoantibodies in hepatitis C and hepatits B infection in China. Intern Med 50, 811–815.
Zhang, X.H., Feng, R., Xu, L.P., Jiang, Q., Jiang, H., Fu, H.X., Liu, H., Niu, T., Wang, X., Hu, J.D., Jiang, M., Wang, Z., Wang, J.W., Ma, H., Xie, Y. D., Zhu, X.L., Wang, H., Wei, L., Huang, X.J. (2015). Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: a multicenter, observational study. Platelets 26, 672–679.
Zhang, X.H., He, Y., Feng, R., Xu, L.P., Jiang, Q., Jiang, H., Lu, J., Fu, H. X., Liu, H., Wang, J.W., Wang, Q.M., Feng, F.E., Zhu, X.L., Xu, L.L., Xie, Y.D., Ma, H., Wang, H., Liu, K.Y., Huang, X.J. (2016). Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: a multicenter, observational study. Platelets 27, 223–229.
Acknowledgements
The authors thank their nurses’ team and technicians in executing this study. We also thank Yang Wang from State Key Laboratory of Translational Cardiovascular Medicine, Fuwai Hospital & Cardiovascular Institute for statistic analysis. This work was supported by National Natural Science Foundation of China (81470343, 81670116), National Natural Science Foundation for Young Scholars of China (81600132), Key Program of National Natural Science Foundation of China (81730004), Beijing Natural Science Foundation (7171013), Beijing Municipal Science and Technology Commission (Z171100001017084), the National Key Research and Development Program of China (2017YFA0105503) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Xue, J., Feng, R., Fu, H. et al. Combined prednisone and levothyroxine improve treatment of severe thrombocytopenia in hepatitis B with compensatory cirrhosis accompanied by subclinical and overt hypothyroidism. Sci. China Life Sci. 61, 924–933 (2018). https://doi.org/10.1007/s11427-017-9250-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9250-1